How Long Before Ketamine Tablet Starts Working for Depression?

One of the most common and most important questions from patients starting ketamine tablet for depression is: when will I notice something? The answer differs from conventional antidepressants in important ways — and understanding the timeline helps you interpret your experience accurately.

The Two Timelines: Acute vs. Antidepressant

The first thing to understand is that ketamine tablet has two distinct timelines that are often confused:

1. Acute psychoactive effects: The dissociation, altered perception, and mental changes during and shortly after taking the dose (see our article on what ketamine tablet feels like). These begin 30–60 minutes after dosing and resolve within 4–6 hours.
2. Antidepressant effects: The reduction in depression symptoms that is the therapeutic goal. This is a different phenomenon — it emerges after the acute effects have resolved, through ketamine-triggered neuroplasticity.

Patients who expect to "feel less depressed" during or immediately after the acute experience are often disappointed — the antidepressant effect is not typically present in that window.

When the Antidepressant Effect Typically Appears

24–72 Hours: The First Signs

Ketamine's most remarkable property is the speed with which antidepressant effects emerge. Most patients who respond to ketamine tablet notice the first signs within:

24–72 hours after the initial doses

What early response looks like:

• A sense of lightness or "lifting" — difficult to describe but distinct from the drug experience itself
• Brief moments of neutral or positive mood that hadn't been present before
• Reduced rumination — the depressive thought loops may quiet somewhat
• Slight improvement in motivation: thinking about activities without immediately dismissing them
• Improved sleep (often one of the first effects to appear)
• Reduced tearfulness or emotional reactivity to triggers that previously felt overwhelming

These early signs are often subtle. Many patients describe them as: "It's not that I felt happy exactly — it's more like I couldn't feel as awful as I usually did."

1–2 Weeks: More Sustained Improvement

As initial treatment continues (multiple doses or sessions), the antidepressant effect typically builds:

• More consistent mood improvement throughout the day
• Anhedonia (inability to feel pleasure or interest) may begin to lift — noticing enjoyment in activities that had become hollow
• Energy levels may improve
• Social withdrawal may ease
• Concentration and cognitive function often improve alongside mood

PHQ-9 scores at 1–2 weeks often show 3–7 point reductions in responding patients.

2–6 Weeks: Full Assessment of Response

The full therapeutic response to an ketamine tablet course is typically assessed at 4–8 weeks of consistent treatment. By this point:

• Responders typically show at least 50% reduction in baseline depression scores (PHQ-9 or MADRS)
• Some patients achieve full remission (PHQ-9 <5)
• Non-responders have shown minimal change despite adequate dosing

If you have not noticed any meaningful change by 6–8 weeks at an appropriate dose, that is important clinical information your prescriber needs to hear. See our guide on monitoring your response for what to track and report.

Factors That Affect When You Notice Response

Protocol Type

Session-based protocols (moderate doses 2–3 times weekly):

• First signs may appear 24–48 hours after the first session
• Full assessment appropriate at 4–6 sessions (2–3 weeks)

Daily low-dose maintenance protocols:

• First signs may take 1–2 weeks to appear (lower daily doses build effect more gradually)
• Full assessment appropriate at 4–8 weeks

After IV induction, transitioning to oral:

• The antidepressant effect from IV may persist into the oral maintenance phase
• Oral maintenance stabilizes rather than initiates response in this case

Dose Adequacy

Patients on sub-therapeutic doses may not respond simply because the dose is insufficient. If you're not noticing anything after 2–4 weeks, discuss with your prescriber whether your dose is appropriate. This is particularly relevant for daily low-dose protocols where the minimum effective dose varies considerably.

Individual Variation

Response timing varies. Some patients notice striking improvement within 24–48 hours of their first dose. Others take 3–4 weeks of consistent therapy before appreciable change occurs. A minority are "slow responders" who need a longer course before effects emerge.

Underlying Psychiatric Complexity

Patients with more complex psychiatric presentations — prominent anxiety, personality disorder features, active trauma responses, significant chronic stressors — may have slower or more partial responses, not because ketamine "isn't working" but because additional therapeutic work is needed to build on the biological foundation ketamine provides.

How to Track Whether It's Working

Systematic tracking is essential:

PHQ-9 weekly: Complete the 9-item questionnaire at the same time each week (many prescribers send this before or after each check-in appointment). A score reduction of 4+ points is generally considered clinically meaningful.

Daily mood rating: A simple 0–10 daily mood rating takes 10 seconds and reveals patterns not visible in weekly snapshots. Do you have more good days? Are the worst days less bad?

Sleep tracking: Note sleep quality, time to fall asleep, and number of awakenings. Sleep often improves before mood does.

Activity tracking: Are you doing things you weren't doing before? Seeing people, going outside, returning to hobbies? Behavioral change often precedes mood change.

Share the data: Report your tracking data to your prescriber at each check-in so they have objective information about your response.

What to Do If It Doesn't Seem to Be Working

First, be patient for at least 4–6 weeks at an appropriate dose. Then:

Tell your prescriber: "I haven't noticed meaningful improvement in my PHQ-9 scores after 6 weeks" is useful clinical information. "I don't think it's working" is less useful — bring data.

Consider dose adjustment: Your prescriber may recommend increasing the dose, changing the formulation (e.g., switching from tablet to troche for higher bioavailability), or increasing dosing frequency.

Consider a different route: If oral hasn't produced response at adequate doses, IV ketamine or Spravato may provide more reliable acute antidepressant effects.

Consider adjunctive therapy: Adding or intensifying psychotherapy alongside ketamine tablet may enhance treatment response.

Consider other diagnoses: Sometimes inadequate response to multiple treatments prompts a diagnostic reassessment — bipolar disorder, ADHD, underlying medical conditions, or substance use can all affect antidepressant response.

Non-response to ketamine tablet is not a final answer on ketamine therapy overall — the route, dose, formulation, and clinical context all matter, and many patients who don't respond to one approach respond to another.

References

• StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
• PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
• MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
• NIMH: Depression — National Institute of Mental Health overview of depressive disorders, treatment-resistant forms, and emerging therapies
• WHO: Depression Fact Sheet — World Health Organization global data on depression prevalence, burden, and treatment approaches